chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had severe pain in my right upper arm where injection was given, radiating into R shoulder.  No swelling or redness noted.  Unable to even move arm due to the severity of pain.  Rated a 10. No treatment was done except to take a pain pill that did not even touch this pain.  Pain has continued ever since that night.  I have taken physical therapy, anti-inflammatory medication, chiropractor treaments and follow up with my doctor.  Nothing has taken the pain away and now I have lost range of motion with my arm because of this vaccine.
Significant reduction in dysautonomia symptoms within days of the administration of a Moderna COVID-19 booster; This spontaneous case was reported by an other health care professional and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Significant reduction in dysautonomia symptoms within days of the administration of a Moderna COVID-19 booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Dysautonomia.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Significant reduction in dysautonomia symptoms within days of the administration of a Moderna COVID-19 booster). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Significant reduction in dysautonomia symptoms within days of the administration of a Moderna COVID-19 booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   The patient took booster shot.  The patient experienced a clinically significant reduction in dysautonomia symptoms within days of the administration of Moderna COVID-19 booster shot on 03-Dec-2021. Unfortunately, the positive effects had begun to wear off. Patient was able to track and to actively participate in conversations during family's Christmas celebration. This was the first time since early 2015 that patient experienced a family gathering without fatigue, pain, or brain fog. But within the past 7 to 10 days, symptoms have resumed at the pre-booster frequency and intensity. Driving, walking the dog, and reading academic articles was a challenge once again. The patient was curious if the diminished benefit was related to the diminished efficacy of the booster or some other process.  No treatment information was provided.
Patient reported rash started on 10/11/17 on upper torso then developed some rash on legs. Patient reported that she had taken BENADRYL and that symptoms were resolving when seen at clinic on 10/12/17.
Heart felt like it was going to burst out of the chest when pulse checked it was 112 and after a few minutes it went down to 89; Sharp onset of Migraines; Intense heart beating when sitting; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 35-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via intramuscular route of administration in the left arm on 19Feb2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced sharp onset of migraines and intense heart beating when sitting. On an unknown date in Aug2021 (also reported as the most recent was last month), the patient experienced that his heart felt like it was going to burst out of her chest and when the patient checked the pulse it was 112 and after a few minutes it went down to 89. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sharp onset of migraines and intense heart beating when sitting was unknown while that of the event heart felt like it was going to burst out of the chest when pulse checked it was 112 and after a few minutes it went down to 89 was resolved on an unknown date in Aug2021.   No follow-up attempts are possible. No further information is expected.
12 hrs p/inject very fussy; 18 hrs p/screaming 3-4hrs; non stop, t103 & unusual crying;
Received Proquad in Left arm on 3/14/2007.  Within 24 hours developed swelling, tenderness, and warmth at site.  These symptoms worsened over following day and was seen in MD's office.  Patient was placed on antibiotics to cover for possible cellulits and told to take benedryl and warm compresses to site to treat likely local reaction to immunization.
Patient received vaccine on 12/3/18 and reported to primary care Dr. on 12/7/18 at 9:20am that he had developed cellulitis and pain all the way down to his fingers from the injection site of his left arm. I tried reaching patient twice on 12/16 @7:05pm and 12/29/18 @10:15am to see how he was doing and got hung up on both times. Filed a report via Agency on 12/31/18.
Pain in armpit, red streak at vaccination site, L arm. Started early morning on 6/18/21, went to ED late 6/18/21 into 6/19/21.
The vaccine administration site is swollen 2 weeks post vaccination. The patient denies pain or fever. The area under the skin is swollen. The area affected is approximately 2.5-3.5 inches wide. Patient advised to follow up with primary care provider.
Minor bilateral hip pain 2 days after the vaccine.  I took 1 or 2 80mg aspirins when I woke up to the sore hips, but then after dropping the kid at school and the pain remained, I took an Aleve, which cleared up the problem. The hip pain never returned.  (Note, this was not a pain pattern / location that I had felt before. Again, it was not disabling, just uncomfortable.)  I also did experience tiredness during the first week that I am unable to quantify. It seemed I tired more quickly than usual and I ended up sleeping a bit more than usual. But again, this was relatively minor, and a bit subjective, especially since I had heard of other experiencing tiredness after the vaccine so I may have been "expecting" it.
Patient developed reddish/purplish discoloration of right distal dorsal 2nd toe 2 weeks after Pfizer COVID-19 booster vaccine. Hist first COVID vaccines were Moderna.  Appears to be COVID toe. No pain. No frostbite or trauma.
PATIENT REPORTS GETTING FEVER, CHILLS, AND HEADACHE.  SHE HAS NEVER HAD ANY ISSUES WITH VACCINES BEFORE.  SHE REPORTS THAT HER SYMPTOMS WERE SO BAD THAT SHE CONSIDERED GOING TO THE EMERGENCY ROOM.
Severe headache, fever, chills and joint  pain starting at 10 pm followed in 2 hours by severe nausea and vomiting for 48 hours. Unable to eat or drink during this period. Poor appetite and malaise for  5 additional days.
rush of heat, nausea, dizziness, and almost black out lasts about 2 minutes happened again at 2:30 PM feel sick for days after
Expired dose administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired dose administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was reported. No concomitant medication was reported.  Reporter stated that on 06-Dec-2021 the vials of Lot 012H21B were placed in refrigerator.
MOM REPORTS THAT AN HOUR AFTER INJECTIONS SHE STARTED RUNNING FEVER 103.6 UNTIL LATER THE NEXT DAY. CHILDS RIGHT UPPER ARM BECAME SWOLLEN, RED AND HOT TO TOUCH. CHILD C/O NOT ABLE TO RAISE THAT ARM. ON OCT 26 NO TEMP, BUT ARM STILL SWOLLEN AND HAD A RASH. TYLENOL AND IBRUPROEN GIVEN. DID NOT REPORT TO DR.
Severe vertigo, tingling in both arms.   Monitored for additional 30 minutes.  Symptoms reduced but remain.  Instructed to go to the ER if symptoms worsened.
I fainted and had a brief seizure. Ever since I am having trouble recalling words and grasping items.
Breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding) in a 3-month-old male infant exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the mother received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): Concurrent medical conditions included Breast feeding.    No Medical History information was reported.    On an unknown date, the mother received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The mother's last menstrual period was on 05-Jun-2020 and the estimated date of delivery was 12-Mar-2021. On an unknown date, the infant was diagnosed with EXPOSURE VIA BREAST MILK (Breastfeeding). The Infant was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The cesarean delivery occurred on 20-Mar-2021, which was reported as Normal Pregnancy Outcome. For neonate 1, The outcome was reported as Delivered NOS. Mother experienced fetal distress on ultrasound, emergency caesarian section performed and delivered the baby. No perinatal complications for the infant, no abnormalities on delivery, no identified infant abnormalities 1 month postpartum. At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Transmammary) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Transmammary), the reporter did not provide any causality assessments.   Concomitant product information was not provided.  No treatment information was provided.   Infant's mother got vaccine in her third trimester.  Upon internal review on 03-Nov-2021, birth type captured as normal pregnancy outcome and fetal outcome captured as delivered NOS.   This case was linked to MOD-2021-004512 (Parent-Child Link).   See case MOD-2021-004512 for details regarding the Parent case.
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever very high) and MYALGIA (Body aches) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 0141L20A) for COVID-19 vaccination. He did not have any history of allergies and history of COVID-19 prior to or after getting the vaccine. The patient's past medical history included Small intestine carcinoma (Had cancer tumors in the small intestines which were removed). Concurrent medical conditions included Pancreas cancer (Has cancer tumors in the pancreas which was still there and still being investigated) and Type 2 diabetes mellitus. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced PYREXIA (Fever very high) and MYALGIA (Body aches). On 15-Feb-2021, PYREXIA (Fever very high) and MYALGIA (Body aches) had resolved. It was reported that the patient had both the cancers which were diagnosed in the past 3-4 years and the patient was not undergoing any chemotherapy,  No concomitant medications were reported. It was mentioned that the patient experienced very high fever after 2nd dose when compared to 1st dose and 1st booster dose which was just 99-100. The patient received shingles vaccine first dose on 12-Oct-2021 and the second dose on 06-Apr-2022. No treatment medications were reported. This case was linked to MOD-2022-541321, MOD-2022-541328 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2022: Follow up received and QE number added.
Pulmonary embolism; This is a spontaneous report from a contactable consumer reporting for her mother.     A 84-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm in Jul2021 (Batch/Lot number was not reported) as single dose  for covid-19 immunisation (age at vaccination 84 years)  .  Medical history included ongoing dementia. Concomitant medications included donepezil (DONEPEZIL) taken for dementia from 2016 and ongoing; memantine (MEMANTINE) taken for dementia from 2016 and ongoing.   In 2021 the patient received the first dose of BNT162B2 vaccine) The patient experienced pulmonary embolism (medically significant) on 29Aug2021 with outcome of unknown.  The patient was hospitalized for pulmonary embolism  from 29Aug2021 to an unknown date. Therapeutic measures were taken as a result of pulmonary embolism including heparin.  Course of the Event: Yesterday morning her mother had a pulmonary embolism to the right lung. She went to the Emergency Room at local hospital. She was treated there and then transferred to the main hospital.  The lot number for the vaccine, was not provided and will be requested during follow up.
approx 1hr p/shots screaming high pitched cry-screamed from 930AM to 7PM & vomiting x 4;fever 100-102 w/APAP
EE had Pfizer COVID vaccine 12/30/20 and 1/18/21. 3/25/21 asymptomatic prevalence test  positive for COVID.
Injection site is lumpy; Injection site is red; Injection site is itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Injection site is lumpy), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE PRURITUS (Injection site is itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Injection site is lumpy), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE PRURITUS (Injection site is itchy). At the time of the report, VACCINATION SITE MASS (Injection site is lumpy), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE PRURITUS (Injection site is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
injection side severe edema and pain treated to Ketorolac  injection, and hydroncotison cream topically.
Arm/Shoulder is getting worse with pain.  Unable to put my coat on as usual.  Compensating for the pain using caution to lift.  The pain is progressively getting worse to point of tears at night and waking me throughout the night.
07/24/02 two days after injection she reports arm hot, swollen, and painful. Feeling very achy and tired for five days. She reported this to the clinic 07/29/02. Said swelling and hotness of arm has gone away but still very tired. Ibuprofin does not help pain.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 28-NOV-2014, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/1 ml (lot#J010613, expiration date 11-JUN-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 48, 1 and R; 8, unknown and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
the day p/vax devel h/a, red face, dizzy, 4" welt @ inj site;about a wk later became ill & went to MD & was told had the old fashion flu;was checked for bacterial meningitis negative;
PATIENT HAS HX OF SEIZURE DISORDER. RECEIVED MMR VACCINE ON AM OF 03/08/2011. TO THE EMERGENCY ROOM APPROXIMATELY 90 MINUTES LATER WITH SEIZURES.  DIAGNOSIS: SEIZURE ACTIVITY WITH SEIZURE DISORDER.  LAST REPORTED SEIZURE PRIOR TO THIS WAS 02/19/2011.  KEPPRA WAS INCREASED FROM 5.5 BIB TO TID AFTER DISCUSSING CASE WITH PEDIATRIC NEUROLOGIST AND ALSO OTHER DR.
Pt's (L) thigh became swollen and painful the night the received the vaccine. he was seen by the doctor 6/14/08 and had difficulty bearing weight on his leg due to pain. He didn't have a fever or redness then but developed both 2 days after injection. Pt treated with Cephalexin.
Patient felt faint and dizzy, the pharmacist and the patients mother talked to the patient but the patients words were slurred. Breathing exercises were tried with the patient. EMS were offered to be called but were declined twice. Blood pressure was taken and the patients mother purchased Gatorade to hydrate her.
patient feeling flushed & light headed. Onset occurred about 10 mins after vac Vitals monitored; no swelling throat/face.  After calming patient, symptoms subsided. Called Dr. for   release/review. 71 y/o female who presents with facial flushing & light headedness that began after her vaccination. No progression or other symptoms. Hx of similar RXN after exercise symptoms. P.E - Mild facial flushing started Possible mild allergic rxn. Plan - home with monitoring.
presented with DKA, weakness; ? Recently dx with Covid PTA; admitted with DKA, NSTEMI; tx with Vit C, Zinc, vanc, zosyn, doxycycline, rocephin, Remdesivir contraindicated due to renal failure and elevated LFT's; Pt intially treated for DKA and stabilized, then developed encephalopathy & hematuria, progressive SOB & hypoxia; CT showed developing Covid PNA and PE, also developed bilateral DVT, ultimately pt coded and family requested CPR to be stopped
patients that were vaccinated with this vaccine after the excursion; No adverse event; patients that were vaccinated with this vaccine after the excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event) in a 49-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. A57162B) for COVID-19 prophylaxis.     It was unknown if the patient had ever been diagnosed or tested positive for Covid-19. Acute illness at the time of vaccination and up to one month before was unknown.  Concurrent medical conditions included Asthma, Hypertension and Depression.    On 05-Oct-2022 at 10:08 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 05-Oct-2022 at 10:08 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (patients that were vaccinated with this vaccine after the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients that were vaccinated with this vaccine after the excursion).    No concomitant medication was reported.  It was reported that Moderna bivalent vaccine was administered after a temperature excursion. Patient did not reported any adverse events.   No treatment information was provided.
PT STATES THAT A FEW HOURS AFTER SHE RECIEVED THE VACCINES, A SMALL, RED, WARM RASH APPEARED ON HER LEFT ARM.  THE REDNESS SPREAD OVER THE COURSE OF 2 DAYS AND SHE RAN A FEVER OF 102 LAST NIGHT.
SORE BACK; BARELY WALK STRAIGHT; SLIGHT FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number:Unknown ,expiry:unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced sore back, barely walk straight, and slight fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight fever, sore back and barely walk straight was not reported. This report was non-serious.
The evening of Sept 10, I began to feel achy and tired, with my right arm being very painful to move. The next day, I had a slight fever in the morning and the achiness was worse, but I expected it. By around 12:30 pm, the effects hit me like a truck. My fever spiked even more, and the achiness turned into a burning ache all along my spine and into my lower ribs that was torturous, since I couldn't make it stop or get away from it. I was prescribed 5mg of prednisone twice a day to help calm down the inflammation and reaction in my body. The next day, my fever was broken and the ache was lessened. It had returned to just the fatigue and heart flutter. However, for about a week after Sept 10, I would get a sensation primarily on my neck and down onto my chest. It felt like the chills running through my body, except it was like needles stabbing me all over in a wave across those areas. It sometimes just randomly happen, but if something caused me to get what normally would've been the chills or goose bumps, I felt that sensation instead.
I was told by the specialist that the PT needed an injection, I gave the injection with the thought that the NP told the specialist to instruct me to give it. That was not that case. The specialist made the call based on what the PT told. Once aware that the PT wasnt supposed to get the injection I alerted all parties as well as management of the incident.
Contacted by caregiver. Patient spiked temperature of 103 deg at about midnight. Unable to bring fever down. Patient is diabetic and unable to take fluids and eat according to caregiver. Blood sugar elevated but unable to provide value.  Patient does not have local primary care provider. Recommended ER visit to evaluate based on health conditions and symptoms
11 day headache/neck pain.  Arm itched and was sore for 7 days. Menses delayed. Heat flushes. Shingles - right wrist.
Pt noted a rash 2 days after administration.  She describes it as raised and hard, a big red area about the size of her palm.  2 days later not as big or hard.  She added some neosporin.
Extreme fatigue lasting over a week, inability to workout without abnormal extreme soreness, poor digestion and nausea for over a week, looking pale and gaunt to the degree of notice by others, overall feeling bad consistently over a week.